Cargando…

Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy

Individuals with Parkinson’s disease (PD) typically receive a diagnosis once they have developed motor symptoms, at which point there is already significant loss of substantia nigra dopamine neurons, α-synuclein accumulation in surviving neurons, and neuroinflammation. Consequently, the point of cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Laar, Amber D., Webb, Katherine R., Keeney, Matthew T., Van Laar, Victor S., Zharikov, Alevtina, Burton, Edward A., Hastings, Teresa G., Glajch, Kelly E., Hirst, Warren D., Greenamyre, J. Timothy, Rocha, Emily M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421849/ https://www.ncbi.nlm.nih.gov/pubmed/37567894 http://dx.doi.org/10.1038/s41531-023-00561-6

Ejemplares similares

α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo
por: Van Laar, Victor S., et al.
Publicado: (2020)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

The link between neuroinflammation and the neurovascular unit in synucleinopathies
por: Wang, Qing, et al.
Publicado: (2023)

STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
por: Hinkle, Jared T., et al.
Publicado: (2022)

Chronic administration of rotenone induces Parkinsonian symptoms and increases levels of nitric oxide in rat brain
por: Bashkatova, Valentina, et al.
Publicado: (2008)

Oligodendroglial α‐synucleinopathy‐driven neuroinflammation in multiple system atrophy
por: Hoffmann, Alana, et al.
Publicado: (2019)

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
por: Terkelsen, Miriam Højholt, et al.
Publicado: (2022)

Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation
por: Zhou, Fang, et al.
Publicado: (2008)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone
por: Javed, Hayate, et al.
Publicado: (2016)

Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone
por: Zhang, Na, et al.
Publicado: (2018)

NADPH oxidase 2 activity in Parkinson’s disease
por: Keeney, Matthew T., et al.
Publicado: (2022)

Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's Disease
por: Marella, Mathieu, et al.
Publicado: (2008)

Duzhong Fang Attenuates the POMC-Derived Neuroinflammation in Parkinsonian Mice
por: Li, Lili, et al.
Publicado: (2021)

Phenothiazine normalizes the NADH/NAD(+) ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease
por: Tapias, Victor, et al.
Publicado: (2019)

β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP(+)) and 6-Hydroxydopamine (6-OHDA)
por: Carli, Marco, et al.
Publicado: (2021)

Non-motor parkinsonian pathology in aging A53T α-Synuclein mice is associated with progressive synucleinopathy and altered enzymatic function
por: Farrell, Kaitlin F, et al.
Publicado: (2014)

Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways
por: Jayaraj, Richard L., et al.
Publicado: (2021)

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
por: Heras-Garvin, Antonio, et al.
Publicado: (2020)

Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration
por: Chung, Lucia Yi-Ru, et al.
Publicado: (2022)

NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice
por: Hernandes, Marina S., et al.
Publicado: (2013)

Diversity of Mitochondrial Pathology in a Mouse Model of Axonal Degeneration in Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2013)

Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology
por: Houser, Madelyn C., et al.
Publicado: (2021)

Intermittent Fasting Applied in Combination with Rotenone Treatment Exacerbates Dopamine Neurons Degeneration in Mice
por: Tatulli, Giuseppe, et al.
Publicado: (2018)

Glial cells modulate retinal cell survival in rotenone-induced neural degeneration
por: Tawarayama, Hiroshi, et al.
Publicado: (2021)

Mechanism of rotenone binding to respiratory complex I depends on ligand flexibility
por: Pereira, Caroline S., et al.
Publicado: (2023)

Demethoxycurcumin, a Natural Derivative of Curcumin Abrogates Rotenone-induced Dopamine Depletion and Motor Deficits by Its Antioxidative and Anti-inflammatory Properties in Parkinsonian Rats
por: Ramkumar, Muthu, et al.
Publicado: (2018)

Limonene, a Monoterpene, Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Modulating Neuroinflammation, Hippo Signaling and Apoptosis in Rats
por: Eddin, Lujain Bader, et al.
Publicado: (2023)

Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
por: Sekiyama, Kazunari, et al.
Publicado: (2012)

An Update on Gene Therapy Approaches for Parkinson’s Disease: Restoration of Dopaminergic Function
por: Van Laar, Amber D., et al.
Publicado: (2021)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
por: Zaman, Vandana, et al.
Publicado: (2022)

Necroptosis and Neuroinflammation in Retinal Degeneration
por: Tao, Yan, et al.
Publicado: (2022)

Development and validation of a plasma-based melanoma biomarker suitable for clinical use
por: Van Laar, Ryan, et al.
Publicado: (2018)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson’s Disease
por: Chen, Leilei, et al.
Publicado: (2021)

Hibiscetin attenuates oxidative, nitrative stress and neuroinflammation via suppression of TNF-α signaling in rotenone induced parkinsonism in rats
por: Alzarea, Sami I., et al.
Publicado: (2022)

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
por: Kim, Changyoun, et al.
Publicado: (2018)

Potential Role of Mic60/Mitofilin in Parkinson’s Disease
por: Van Laar, Victor S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qsv4kedsa4kv3po75phbatou86